Details for 2018212173
Up to date per 02.04.2026
Actions
Details for 2018212173
Granted/Registered
European Patent
29.05.2019 A
07.10.2020 B1
20.01.2012
US
201213354714
A61K 9/70 20060101AFI20190403BHEP
Owner
LTS Lohmann Therapie-Systeme AGLohmannstraße 2 56626 AndernachDE
Santhera Pharmaceuticals (Schweiz) AGHohenrainstrasse 24 4133 PrattelnCH
Representative
Representative
Dipl.Ing. Dr. techn. Elisabeth SchoberFlorianigasse 26/21080 WienAT
Inventor
Krumme, MarkusBinningerstrasse 53 4123 AllschwilCH
Jensen, Keith7 Bradley Rd. Arlington, MA 02474US
Dubach-Powell, JudithBienenstrasse 5 4104 OberwilCH
Hausmann, RudolfSt. Alban Anlage 33 4052 BaselCH
Information about Fees